MECP
Rett Syndrome: MECP2 Sequencing
Rett Syndrome: MECP2 Sequencing
MECP2 sequencing is a molecular test used to identify variants in the gene associated with Rett syndrome. This test can also confirm a diagnosis and identify disease-causing variants within a family to facilitate carrier screening.
Rett syndrome
Clinical Information
A neurodevelopmental disorder that affects females, Rett syndrome is associated with cortical atrophy, stereotypical hand movements and severe intellectual disability. With an incidence of 1 in 10,000 – 15,000, it is one of the most common causes of intellectual disability in females. Rett syndrome is characterized by loss of acquired skills after a period of normal development in infancy.
Most cases of Rett syndrome are caused by an abnormality (missense variant, nonsense variant or deletion) of MECP2. Additionally, a specific phenotype has been identified in males with a MECP2 duplication that is identifiable by MLPA. These males display hypotonia that progresses to spasticity, severe intellectual disability and recurrent pulmonary infections. Females in these families who have the duplication are clinically unaffected and display a near total skewing of X-inactivation. Sequencing of the MECP2 gene and MLPA deletion/duplication analysis can be ordered concurrently, sequentially or separately.
Technical Information
Specimen Requirements
Transport Instructions
Connect With Our Experts
Call 1-800-473-9411 to speak with our team of laboratory genetic counselors for questions or additional information.
Robin Fletcher, MS, CGC
Falecia Thomas, MS, CGC
Alex Finley, MS, CGC
